Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Inventory Average: 2021-2025

Historic Inventory Average for Ascendis Pharma A (ASND) over the last 4 years, with Sep 2025 value amounting to $348.2 million.

  • Ascendis Pharma A's Inventory Average rose 747.48% to $348.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.2 million, marking a year-over-year increase of 747.48%. This contributed to the annual value of $272.4 million for FY2024, which is 52.11% up from last year.
  • Ascendis Pharma A's Inventory Average amounted to $348.2 million in Q3 2025, which was up 6.87% from $325.8 million recorded in Q2 2025.
  • Ascendis Pharma A's Inventory Average's 5-year high stood at $348.2 million during Q3 2025, with a 5-year trough of -$53.8 million in Q3 2024.
  • Over the past 3 years, Ascendis Pharma A's median Inventory Average value was $99.5 million (recorded in 2024), while the average stood at $123.6 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Inventory Average slumped by 158.77% in 2024, and later skyrocketed by 1,013.77% in 2025.
  • Quarterly analysis of 5 years shows Ascendis Pharma A's Inventory Average stood at $10.5 million in 2021, then skyrocketed by 395.74% to $52.3 million in 2022, then surged by 54.20% to $80.6 million in 2023, then surged by 57.51% to $126.9 million in 2024, then surged by 747.48% to $348.2 million in 2025.
  • Its last three reported values are $348.2 million in Q3 2025, $325.8 million for Q2 2025, and $312.1 million during Q1 2025.